Cite
MLA Citation
Sharon Nachman et al.. “Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1–Infected Children Aged 2 Through 18 Years.” Clinical infectious diseases, vol. 58, 2014, pp. 413–422. http://access.bl.uk/ark:/81055/vdc_100151521097.0x00004f